An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
Adrienne B ShannonRichard J StrakerMichael J CarrJames SunKarenia LandaKirsten BaecherKevin LynchHarrison G BartelsRobyn PanchaudLuke J KeeleMichael C LoweCraig L SlingluffMark J JamesonKenneth Y TsaiMark B FariesGeorgia M BeasleyVernon K SondakGiorgos C KarakousisJonathan S ZagerJohn T MiuraPublished in: Annals of surgical oncology (2022)
A risk-score model, including patient and tumor factors, based on DSS improves prognostic assessment of patients with clinically localized MCC. This may inform surveillance strategies and patient selection for adjuvant therapy trials.
Keyphrases